Cracking the genetic code of a rare kidney cancer
In a groundbreaking study, researchers have decoded the genetic makeup of a rare kidney cancer known as reninoma.
AI’s potential in predicting esophageal and stomach Cancer
For fifty years, Western nations have faced a rising wave of lethal esophageal and stomach cancer. AI's predictive capability in these cancers is now evident.
The impact of weight loss surgery on Cancer prevention
New research reveals that weight loss surgery is linked to reduced cancer incidence and mortality, particularly among females.
Impact of assisted suicide on Cancer-related deaths
A study in Cancer Medicine examines trends in self-initiated deaths among cancer patients in Switzerland over 20 years, comparing assisted suicide.
How can AI oncology diagnostics help the NHS?
DeepMed has developed an AI oncology diagnostics system, DeepPathTM - LYDIA, to assist histopathologists in performing lymph node metastasis detection quickly and accurately.
Nutrition research for acute childhood leukaemia
Dr Zisis Kozlakidis explores the value of nutrition in acute childhood leukaemia diagnosis and treatment.
Photodynamic Therapy: Killing cancer gently with visible light
Photodynamic therapy, using visible light with lower energy, causes fewer side effects when treating cancer, find Drs. Mary Potasek, Evgueni Parilov, and Karl Beeson, Co-founders of Simphotek, Inc.
Breast cancer survival rate sees a 66% improvement over 20 years
Women with early stage breast cancer today are 66% less likely to die within five years of diagnosis than they were in the 1990s, research on the breast cancer survival rate finds.
Following cancer prevention recommendations reduces risk of the disease
Following global cancer prevention recommendations reduces the risk of developing the disease according to latest study.
Universal receptor system allows customizable immunotherapies for cancer
A universal receptor system that enables T cells to recognize any cell surface target has been created by University of Pittsburgh researchers, which could revolutionise customizable immunotherapies for treating cancer and other diseases.
How AI can optimise early cancer treatment
Early cancer treatment is vital to sustaining high cancer survival rates, but could AI improve clinician capabilities and predict worse cases?
Improving cancer therapy using sonoenhancement with acoustic cluster therapy
Sonoenhancement with Acoustic Cluster Therapy (ACT®) improves drug delivery to solid tumors, and by that reduces the necessary doses and side effects.
Can neurodevelopmental disorders affect testicular cancer occurrence?
Research finds that men who have a neurodevelopmental disorder, such as autism and ADHD, also have a slightly increased risk of testicular cancer.
Can AI be used to predict and prevent breast cancer?
Lester Litchfield, Head of Data Science at Volpara Health, discusses the future of artificial intelligence in breast health.
Cancer survival rates rise by 9% nationally in the NHS
NHS England has published a one-year cancer survival index, showing how cancer survival rates have improved across the country by almost 10%.
Advancements in how we identify and treat hypoxic cancers
Cancers that are starved of oxygen, otherwise known as hypoxic cancers, are generally difficult to identify – but medical imaging has taken a new step with the MR-Linac scanner.
Intelligent triage: a vital step toward resolving the problem of capacity in NHS cancer...
AI offers an opportunity to reimagine our approach to cancer diagnostics, leveraging data to build a more robust and efficient system for cancer referrals.
Machine learning and prognostics in cancer programmes
Tim Simpson, General Manager of Hologic UK & Ireland, discusses how AI, machine learning and prognostics could revolutionise cancer detection and treatment in breast and cervical cancer programmes.
Can technology help detect brain tumours through urine analysis?
Researchers have revealed a new and non-invasive way to detect brain tumours through a device that identifies a key membrane protein in a patient's urine.
Addressing the chasm in UK cancer care
Stefan Doroszkowski, Managing Director at Amethyst Radiotherapy Group UK, shares his stance on responding to the cancer care crisis, addressing the chasm in UK cancer care.